RSS Europäische Arzneimittel-Agentur (EMA) | Was gibt's Neues Folgen Orphan-Status: Avutometinib,Defactinib Behandlung von Eierstockkrebs, 18/07/2025 Positiv Orphan designation: avutometinib,defactinib Treatment of ovarian cancer, 18/07/2025 Positive ema.europa.eu
